Evidence map›Paper›PMID 26145443›Full record

ArticleScientific reports2015

RASA: Robust Alternative Splicing Analysis for Human Transcriptome Arrays.

Junhee Seok, Weihong Xu, Ronald W Davis, Wenzhong Xiao

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomics of injury: The Glue Grant experience.The journal of trauma and acute care surgery · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Junhee SeokSchool of Electrical Engineering, Korea University, Seoul 136-701, Korea.
Weihong XuStanford Genome Technology Center, Palo Alto, CA 94304, USA.
Ronald W DavisStanford Genome Technology Center, Palo Alto, CA 94304, USA.
Wenzhong Xiao1] Stanford Genome Technology Center, Palo Alto, CA 94304, USA [2] Massachusetts General Hospital and Shriners Hospital for Children, Boston, MA 02114, USA.

Funding

WHOLE YEAST GENOME TRANSCRIPTIONAL AND FUNCTIONAL GENE MAPS--A FEASIBILITY STUDYP01HG000205 · NHGRI · STANFORD UNIVERSITY · PI DAVIS, RONALD WAYNE, HOWE, ROGER THOMAS · 1990 to 2016
$120.9M
Inflammation and the Response to InjuryU54GM062119 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MOLDAWER, LYLE L · 2001 to 2010
$78.6M
Bedside Genomics in Severe TraumaR01GM101401 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI TOMPKINS, RONALD GARY, XIAO, WENZHONG · 2012 to 2013
$826k
NHGRI NIH HHS P01 HG000205NHGRI NIH HHS P01-HG00205NIGMS NIH HHS R01 GM101401NIGMS NIH HHS R01-GM101401NIGMS NIH HHS U54 GM062119NIGMS NIH HHS U54-GM62119
6 · The paper itself

Abstract

Human transcriptome arrays (HTA) have recently been developed for high-throughput alternative splicing analysis by measuring signals not only from exons but also from exon-exon junctions. Effective use of these rich signals requires the development of computational methods for better gene and alternative splicing analyses. In this work, we introduce a computational method, Robust Alternative Splicing Analysis (RASA), for the analysis of the new transcriptome arrays by effective integration of the exon and junction signals. To increase robustness, RASA calculates the expression of each gene by selecting exons classified as not alternatively spliced. It then identifies alternatively spliced exons that are supported by both exon and junction signals to reduce the false positives. Finally, it detects additional alternative splicing candidates that are supported by only exon signals because the signals from the corresponding junctions are not well detected. RASA was demonstrated with Affymetrix HTAs and its performance was evaluated with mRNA-Seq and RT-PCR. The validation rate is 52.4%, which is a 60% increase when compared with previous methods that do not use selected exons for gene expression calculation and junction signals for splicing detection. These results suggest that RASA significantly improves alternative splicing analyses on HTA platforms.

Indexed as

TranscriptomeAlternative SplicingExonsGTPase-Activating ProteinsHumansLiverMuscle, SkeletalNerve Tissue ProteinsOligonucleotide Array Sequence AnalysisReal-Time Polymerase Chain ReactionRNA, MessengerGTPase-Activating ProteinsNerve Tissue ProteinsRALGAPA1 protein, humanRNA, Messenger

Identifiers

PMID26145443
PMCPMC4491729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.